News and presentations

Press release 2015-06-15
Clanotech's lead compound in development, CLT-28643, has recently been granted a European Patent by the European Patent Office.

Press release 2015-05-12
Clanotech AB to present CLT-28643 in the treatment of eye disease at BioTrinity 2015 on 13 May 2015

Press release 2015-05-12
Clanotech receives orphan drug designation in the U.S.


Press release 2014-10-20
Clanotech receives orphan drug designation in the EU
Swedish version: Clanotech får särläkemedelsstatus i EU


Clanotech Presentation September 2013

Press release 2011-01-13
Tom Pike appointed chairman of Clanotech AB’s board

Press release 2010-03-25
Bo Öberg new member of the Clanotech's board

Bo Öberg ny styrelseledamot i Clanotech

 
ClanoTech AB • Fogdevreten 2 • S-17165 Solna • Sweden • Org. nr. 556706-6658 • Registered office: Solna